147 related articles for article (PubMed ID: 33372915)
1. [Analysis of the degree of clinical suspect in patients with congenital adrenal hyperplasia by 21-hydroxylase deficiency before obtaining the result of the newborn screening program of the autonomous Community of Madrid.].
Sanz Fernández M; Mora Sitja M; Carrascón González Pinto L; Rodríguez Sánchez A
Rev Esp Salud Publica; 2020 Dec; 94():. PubMed ID: 33372915
[TBL] [Abstract][Full Text] [Related]
2. Assessment of the Degree of Clinical Suspicion of 21-Hydroxylase Deficiency Prior to the Newborn Screening Result.
Sanz Fernández M; Mora Sitja M; Carrascón González-Pinto L; López Herce Arteta E; Rodríguez Sánchez A
Horm Metab Res; 2023 Aug; 55(8):528-535. PubMed ID: 37328149
[TBL] [Abstract][Full Text] [Related]
3. Clinical characteristics of Taiwanese children with congenital adrenal hyperplasia due to 21-hydroxylase deficiency detected by neonatal screening.
Liu SY; Lee CT; Tung YC; Chien YH; Hwu WL; Tsai WY
J Formos Med Assoc; 2018 Feb; 117(2):126-131. PubMed ID: 28392195
[TBL] [Abstract][Full Text] [Related]
4. A rational, non-radioactive strategy for the molecular diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Coeli-Lacchini FB; Turatti W; Elias PC; Elias LL; Martinelli CE; Moreira AC; Antonini SR; de Castro M
Gene; 2013 Sep; 526(2):239-45. PubMed ID: 23570880
[TBL] [Abstract][Full Text] [Related]
5. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia between 1995 and 2006.
Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
Horm Res; 2009; 72(4):247-51. PubMed ID: 19786796
[TBL] [Abstract][Full Text] [Related]
6. Molecular testing in congenital adrenal hyperplasia due to 21α-hydroxylase deficiency in the era of newborn screening.
Sarafoglou K; Lorentz CP; Otten N; Oetting WS; Grebe SK
Clin Genet; 2012 Jul; 82(1):64-70. PubMed ID: 21534945
[TBL] [Abstract][Full Text] [Related]
7. Clinical and molecular profile of newborns with confirmed or suspicious congenital adrenal hyperplasia detected after a public screening program implementation.
Kopacek C; Prado MJ; da Silva CMD; de Castro SM; Beltrão LA; Vargas PR; Grandi T; Rossetti MLR; Spritzer PM
J Pediatr (Rio J); 2019; 95(3):282-290. PubMed ID: 29715434
[TBL] [Abstract][Full Text] [Related]
8. 21-Hydroxylase deficiency: clinical features, laboratory profile and pointers to diagnosis in Indian children.
Bajpai A; Kabra M; Menon PS
Indian Pediatr; 2004 Dec; 41(12):1226-32. PubMed ID: 15623903
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the Dutch neonatal screening for congenital adrenal hyperplasia.
van der Linde AAA; Schönbeck Y; van der Kamp HJ; van den Akker ELT; van Albada ME; Boelen A; Finken MJJ; Hannema SE; Hoorweg-Nijman G; Odink RJ; Schielen PCJI; Straetemans S; van Trotsenburg PS; Claahsen-van der Grinten HL; Verkerk PH
Arch Dis Child; 2019 Jul; 104(7):653-657. PubMed ID: 30712004
[TBL] [Abstract][Full Text] [Related]
10. Classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency - the next disease included in the neonatal screening program in Poland.
Ginalska-Malinowska M
Dev Period Med; 2018; 22(2):197-200. PubMed ID: 30056407
[TBL] [Abstract][Full Text] [Related]
11. Classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in croatia between 1995 and 2006.
Dumic K; Krnic N; Skrabic V; Stipancic G; Cvijovic K; Kusec V; Stingl K
Horm Res; 2009; 72(5):310-4. PubMed ID: 19844117
[TBL] [Abstract][Full Text] [Related]
12. Molecular genetic analysis in 93 patients and 193 family members with classical congenital adrenal hyperplasia due to 21-hydroxylase deficiency in Croatia.
Dumic KK; Grubic Z; Yuen T; Wilson RC; Kusec V; Barisic I; Stingl K; Sansovic I; Skrabic V; Dumic M; New MI
J Steroid Biochem Mol Biol; 2017 Jan; 165(Pt A):51-56. PubMed ID: 27041116
[TBL] [Abstract][Full Text] [Related]
13. [Congenital adrenal hyperplasia salt-wasting form in males during the neonatal period. Can we anticipate to metabolic emergency?].
Gebara E; Fernández MA; Rojas E; Amin A; López MR
Arch Argent Pediatr; 2009 Aug; 107(4):369-73. PubMed ID: 19753447
[TBL] [Abstract][Full Text] [Related]
14. Application of Principal Component Analysis to Newborn Screening for Congenital Adrenal Hyperplasia.
Lasarev MR; Bialk ER; Allen DB; Held PK
J Clin Endocrinol Metab; 2020 Aug; 105(8):. PubMed ID: 32525982
[TBL] [Abstract][Full Text] [Related]
15. Initial presentations and associated clinical findings in patients with classical congenital adrenal hyperplasia.
Milyani AA; Al-Agha AE; Al-Zanbagi M
J Pediatr Endocrinol Metab; 2018 Jun; 31(6):671-673. PubMed ID: 29750654
[TBL] [Abstract][Full Text] [Related]
16. Presenting status of children with classical congenital adrenal hyperplasia over two decades (1999-2018) in the absence of newborn screening in Sri Lanka.
Seneviratne SN; Sandakelum U; Jayawardena CH; Weerasinghe AM; Wickramarachchi PS; de Silva S
J Pediatr Endocrinol Metab; 2021 Sep; 34(9):1131-1137. PubMed ID: 34192833
[TBL] [Abstract][Full Text] [Related]
17. A three-year follow-up of congenital adrenal hyperplasia newborn screening.
Pezzuti IL; Barra CB; Mantovani RM; Januário JN; Silva IN
J Pediatr (Rio J); 2014; 90(3):300-7. PubMed ID: 24560529
[TBL] [Abstract][Full Text] [Related]
18. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.
Miller WL
Horm Res Paediatr; 2019; 91(6):416-420. PubMed ID: 31450227
[TBL] [Abstract][Full Text] [Related]
19. Nationwide neonatal screening for congenital adrenal hyperplasia in sweden: a 26-year longitudinal prospective population-based study.
Gidlöf S; Wedell A; Guthenberg C; von Döbeln U; Nordenström A
JAMA Pediatr; 2014 Jun; 168(6):567-74. PubMed ID: 24733564
[TBL] [Abstract][Full Text] [Related]
20. Impact of Newborn Screening on Clinical Presentation of Congenital Adrenal Hyperplasia.
Navardauskaitė R; Banevičiūtė K; Songailienė J; Grigalionienė K; Čereškevičius D; Šukys M; Mockevicienė G; Smirnova M; Utkus A; Verkauskienė R
Medicina (Kaunas); 2021 Sep; 57(10):. PubMed ID: 34684072
[No Abstract] [Full Text] [Related]
[Next] [New Search]
